The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy. [electronic resource]
Producer: 20010809Description: 537-54 p. digitalISSN:- 0968-0896
- Administration, Oral
- Animals
- Antirheumatic Agents -- chemical synthesis
- Arthritis -- chemically induced
- Biological Availability
- Cytochrome P-450 CYP1A1 -- drug effects
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Stability
- Enzyme Induction -- drug effects
- Enzyme Inhibitors -- chemical synthesis
- Female
- Humans
- Imidazoles -- chemical synthesis
- Inhibitory Concentration 50
- Lipopolysaccharides -- pharmacology
- Mice
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Monocytes -- drug effects
- Rats
- Rats, Sprague-Dawley
- Structure-Activity Relationship
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- p38 Mitogen-Activated Protein Kinases
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.